India’s AI Nationalism: A Stack Built on Foreign Foundations? Mukesh Ambani, India’s most influential industrialist, is placing an astonishing $110 billion bet on artificial intelligence, aiming to infuse every call, every app, and every Read More
The Unintended Endorsement: When Washington Advertises AI The United States government’s recent intervention to halt the public release of Anthropic’s Fable 5 and Mythos 5 models isn’t a setback for the AI developer; it’Read More
The Illusion of Control in the Digital Age The US Commerce Department’s recent directive, forcing Anthropic to suspend access to its advanced Fable and Mythos AI models, feels less like a strategic intervention and Read More
The US government did not merely ban Anthropic’s Fable 5 and Mythos 5 last week; it inadvertently unveiled the precarious new architecture of AI regulation, one built on commercial intelligence rather than independent oversight. The official Read More
The Lure of the AI Frontier The quiet departure of John Jumper, a Nobel laureate in chemistry, from Google DeepMind to Anthropic is not merely a high-profile personnel change. This move, following closely on the Read More
The Invisible Patch and User Agency A Bluetooth eavesdropping vulnerability isn’t just a technical glitch; it’s a silent invasion, quietly fixed without a public recall, impacting millions. Apple’s recent patch for its Read More
The Forge of Deterrence, The Cradle of Export A proposed $6.6 billion over six years isn’t merely a defense budget; it’s an industrial declaration. Taiwan’s Ministry of National Defense is not just seeking Read More
The High Price of Orbital Indecision The quiet directive to cease work on the Habitation and Logistics Outpost, or HALO, module isn’t just a technical adjustment; it’s a stark, billion-dollar testament to the Read More
The Known Flaws of ‘Objective’ AI The United Kingdom is about to make a perilous wager on imperfect technology, and the stakes are human lives. Starting next year, the British government plans to deploy facial Read More
The Regulatory Gauntlet: Science vs. Politics A 9-0 vote for a new vaccine might sound like the purest form of scientific consensus, a triumph of data over doubt. But when the FDA’s advisory committee Read More